G1 Therapeutics to Release Second Quarter 2024 Financial Results and Provide Business Update on August 8, 2024

Rhea-AI Summary

G1 Therapeutics (Nasdaq: GTHX), a commercial-stage oncology company, has announced its upcoming second quarter 2024 financial results and business update webcast and conference call. The event is scheduled for Thursday, August 8, 2024, at 8:30 a.m. ET. Interested parties can register online to receive dial-in information and a unique PIN for the live conference call. While not mandatory, it's recommended to join 10 minutes before the event starts.

A live and archived webcast will be available on the company's website under the Events & Presentations page. The webcast will remain accessible for 90 days following the event, providing an opportunity for those unable to attend the live call to review the information later.

News Market Reaction

+5.90%

1 alert

+5.90% News Effect

On the day this news was published, GTHX gained 5.90%, reflecting a notable positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

RESEARCH TRIANGLE PARK, N.C., July 25, 2024 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, will host a webcast and conference call to provide a financial and corporate update for the second quarter of 2024 on Thursday August 8, 2024, at 8:30 a.m. ET.

To register for the event and receive a dial in number and unique PIN to access the live conference call, please follow this link to register online. While not required, it is recommended that you join 10 minutes prior to the start of the event. A live and archived webcast will be available on the Events & Presentations page of the company’s website: www.g1therapeutics.com. The webcast will be archived on the same page for 90 days following the event.

About G1 Therapeutics

G1 Therapeutics, Inc. is a commercial-stage oncology biopharmaceutical company whose mission is to develop and deliver next-generation therapies that improve the lives of those affected by cancer, including the Company’s first commercial product, COSELA® (trilaciclib). G1’s goal is to provide innovative therapeutic advances for people living with cancer. G1 is based in Research Triangle Park, N.C.  For additional information, please visit http://www.g1therapeutics.com and follow us on X (formerly known as Twitter) @G1Therapeutics and LinkedIn.

G1 Therapeutics® and the G1 Therapeutics logo and COSELA® and the COSELA logo are trademarks of G1 Therapeutics, Inc.

G1 Therapeutics Contact:

Will Roberts
Communications Officer
Vice President, Investor Relations and Corporate Communications
(919) 907-1944
wroberts@g1therapeutics.com

FAQ

When will G1 Therapeutics (GTHX) release its Q2 2024 financial results?

G1 Therapeutics (GTHX) will release its second quarter 2024 financial results and provide a business update on Thursday, August 8, 2024, at 8:30 a.m. ET.

How can investors access G1 Therapeutics' (GTHX) Q2 2024 earnings call?

Investors can access G1 Therapeutics' (GTHX) Q2 2024 earnings call by registering online to receive a dial-in number and unique PIN. A live and archived webcast will also be available on the company's website.

Where can I find the archived webcast of G1 Therapeutics' (GTHX) Q2 2024 earnings call?

The archived webcast of G1 Therapeutics' (GTHX) Q2 2024 earnings call will be available on the Events & Presentations page of the company's website (www.g1therapeutics.com) for 90 days following the event.

What time should I join G1 Therapeutics' (GTHX) Q2 2024 earnings call?

While not required, it is recommended to join G1 Therapeutics' (GTHX) Q2 2024 earnings call 10 minutes prior to the start of the event, which is scheduled for 8:30 a.m. ET on August 8, 2024.